Products
Platform
Research
Market
Learn
Valiant Laboratories Ltd Financials Statements
Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios
Consolidate
Standalone
Total Qtr Revenue cr | 47.07 | 47.48 | 55.47 | 36.81 | 24.84 |
| Other Income Qtr Cr | 0.87 | 0.66 | -2.31 | 1.58 | 3.36 |
| Operating Revenues Qtr | 46.20 | 46.82 | 57.79 | 35.23 | 21.48 |
Loading chart... | |||||
Operating Expenses Qtr | 46.12 | 44.42 | 53.96 | 34.61 | 28.22 |
Operating Profit Qtr | 0.08 | 2.40 | 3.83 | 0.62 | -6.74 |
EBITDA Qtr Cr | 0.94 | 3.05 | 1.51 | 2.20 | -3.38 |
Depreciation Qtr | 0.53 | 0.53 | 0.52 | 0.52 | 0.52 |
Net Profit Qtr | 0.20 | 1.82 | 0.70 | 2.35 | -4.74 |
Basic EPS Qtr | 0.04 | 0.42 | 0.16 | 0.54 | -1.09 |
Open Demat Account
Open Demat Account